AI in Science: AlphaFold

AlphaFold is an artificial intelligence system developed by DeepMind that predicts the three-dimensional shape of proteins from their amino acid sequences — a problem that had stumped biologists for over fifty years. It matters because protein shape determines protein function, and understanding that link is foundational to medicine, drug discovery, and our understanding of life itself. The remarkable fact: AlphaFold solved in months what the entire global scientific community had been unable to crack in half a century, and then DeepMind gave its predictions away for free to every researcher on Earth.

The core insight

Every protein is a long chain of chemical building blocks called amino acids, and that chain folds itself into a precise three-dimensional shape — the same shape, every single time — determined entirely by the sequence of those building blocks. The shape is everything: it decides what the protein can do, what it can grab onto, and whether a drug molecule will fit it like a key in a lock. AlphaFold's insight was that this folding problem, which chemists had attacked with physics and equations, could instead be treated as a pattern-recognition problem — and that modern deep learning, trained on the library of already-known protein structures, could learn the hidden rules of folding that nature had been using for billions of years.

How It Works

To understand how AlphaFold works, it helps to think about how you might recognize a face you have never seen before. You do not compute every bone angle or skin texture from scratch — you draw on millions of past faces you have seen, and your brain finds the pattern that fits. AlphaFold does something similar, but for molecular shapes.

Step 1 — Reading the sequence. AlphaFold starts with a string of letters representing the amino acid sequence of a protein. Each letter stands for one of twenty possible chemical building blocks, like beads on a necklace.

Step 2 — Searching evolutionary history. The system searches enormous databases of protein sequences collected from thousands of different species. Because evolution preserves what works, two amino acids that always appear together across millions of years of evolution are almost certainly physically close to each other in the folded protein. AlphaFold mines this co-evolution signal as a treasure map of spatial relationships.

Step 3 — Building a relationship map. Using a powerful neural network architecture called a transformer — the same family of models behind modern language AI — AlphaFold builds a rich table of predictions about which amino acids are near which other amino acids in 3D space, even before it knows the full shape.

Step 4 — Iterative refinement. The system passes its predictions back through itself multiple times, each pass refining its understanding, like a sculptor who keeps stepping back to look at the whole figure before adding another detail.

Step 5 — Outputting a structure. Finally, AlphaFold produces a complete 3D coordinate map of every atom in the protein, along with a confidence score for each region — the system genuinely knows which parts of its answer it is sure about and which parts are uncertain. The key innovation was combining evolutionary signals, transformer-style attention across the amino acid sequence, and iterative self-correction all in one end-to-end trained system.

researcher · John Jumper | b. 1985 | Lead Developer of AlphaFold 2

John Jumper trained as a computational chemist and physicist before joining DeepMind, bringing rare expertise in both the biology of protein folding and the engineering of large neural networks. He led the team that built AlphaFold 2 — the version that stunned the world at the CASP14 competition in 2020 — designing the novel Evoformer architecture that processes evolutionary and structural information simultaneously. In 2024, Jumper shared the Nobel Prize in Chemistry for this work, becoming one of the youngest Nobel laureates in the prize's history and the first to win it primarily for developing an AI system.

researcher · Demis Hassabis | b. 1976 | Founder of DeepMind and AlphaFold Vision

Demis Hassabis is a former child chess prodigy, video game designer, and neuroscientist who founded DeepMind in 2010 with the explicit goal of using artificial intelligence to accelerate scientific discovery. He championed the protein folding problem as a grand challenge for AI, arguing years before AlphaFold's success that deep learning could unlock it. In 2024, Hassabis shared the Nobel Prize in Chemistry alongside Jumper — an extraordinary outcome for someone trained primarily as a computer scientist and cognitive neuroscientist rather than a chemist.

Figure
AlphaFold Pipeline: From Sequence to Structure
AlphaFold: Sequence → Structure Pipeline Amino Acid Sequence M-A-G-V-T... Evolutionary Database Search (MSA) Evoformer Transformer blocks 48 layers deep pair + sequence reps Structure Module 3D coordinates Iterative Recycling (×3) + pLDDT confidence score Input Co-evolution signals Key innovation Standard stages
Figure
The Protein Folding Problem Visualized
From Flat Sequence to 3D Shape Amino Acid Sequence (1D) M A G V T L P hundreds to thousands of residues AlphaFold predicts 3D Folded Structure α-helix β-sheet loop ● High confidence ● Lower confidence

Intuition

The Mental Model

Imagine you have never seen a folded origami crane, but you have a book of a thousand photographs showing completed cranes alongside the precise sequence of folds that made each one. After studying enough examples, you begin to notice patterns: certain sequences of early folds always lead to the same later shapes; certain crease combinations never appear together in a finished crane. Given a new fold sequence you have never seen, you could make a surprisingly good guess about what the finished shape looks like — not by physically folding paper, but by pattern-matching to everything you have learned. AlphaFold does exactly this, but the "fold instructions" are amino acid letters, and the "shapes" are the three-dimensional sculptures those letters produce. There is one additional trick that makes it more powerful: evolution has been running experiments for three billion years. If the same stretch of amino acids appears in a fish, a mushroom, and a bacterium all doing the same job, evolution has essentially confirmed that that sequence folds into a stable, functional shape. AlphaFold reads this ancient experimental record and uses it as a guide. The confidence scores AlphaFold reports are like a good student flagging which parts of their exam they are sure of and which parts they guessed on. Regions of a protein that are floppy or variable in real life show up as low-confidence predictions — the system is not just right, it also knows when it might be wrong, which is a hallmark of genuinely useful scientific tools.

Historical Development

Origins · 1 minhow this was discovered
History
1962
Christian Anfinsen demonstrates experimentally that a protein's amino acid sequence alone determines its 3D shape — a discovery that wins him the 1972 Nobel Prize in Chemistry and defines the protein folding problem.
1971
The Protein Data Bank (PDB) is established as a public archive of experimentally determined protein structures, beginning with just 7 entries. It becomes the training data that would eventually power AlphaFold.
1994
The Critical Assessment of protein Structure Prediction (CASP) competition is founded, creating a rigorous global benchmark where teams predict protein structures before experimental results are revealed — the scientific "Olympics" that AlphaFold would eventually dominate.
2018
DeepMind enters CASP13 with AlphaFold 1, a deep learning approach that beats all competitors but still falls short of experimental accuracy for many proteins — a promising but incomplete result.
2020
AlphaFold 2 enters CASP14 and achieves a median score of 92.4 out of 100 on the global distance test — so far ahead of all other teams that many structural biologists describe it as essentially solving the problem. The protein folding problem, 50 years old, is widely declared solved.
2021
DeepMind publishes the AlphaFold 2 paper in the journal Nature and releases the open-source code; simultaneously, they partner with the European Bioinformatics Institute (EMBL-EBI) to launch the AlphaFold Protein Structure Database.
2022
The AlphaFold Database expands to cover over 200 million protein structure predictions — virtually every known protein from every sequenced organism on Earth — all freely available to any researcher.
2023
AlphaFold is used to predict structures of proteins from the malaria parasite, neglected tropical disease pathogens, and multiple cancer-related targets, demonstrating real-world drug discovery impact; newer systems like ESMFold and RoseTTAFold emerge, inspired by AlphaFold's approach.
2024
Demis Hassabis and John Jumper are awarded the Nobel Prize in Chemistry, shared with David Baker (for computational protein design), marking the first time a Nobel Prize in the sciences is awarded primarily for an AI system's contributions.

Why It Matters

Real-World Impact
Drug DiscoveryPharmaceutical companies now use AlphaFold predictions as a starting point when designing new drugs. Knowing the exact shape of a disease-related protein tells chemists which molecules might fit into it like a key into a lock — dramatically narrowing the search from billions of chemical possibilities to a manageable shortlist.
Neglected Tropical DiseasesThe Drugs for Neglected Diseases initiative used AlphaFold structures for Chagas disease, leishmaniasis, and sleeping sickness — illnesses that affect millions of the world's poorest people but historically attracted little pharmaceutical investment because there was no profit motive. Free access to structure predictions changes that calculus.
Malaria ResearchAlphaFold predicted structures for nearly all proteins of Plasmodium falciparum, the most deadly malaria parasite. Many of these proteins had resisted experimental structure determination for decades; AlphaFold provided usable models within months, opening new avenues for vaccine and drug development.
Antibiotic ResistanceWith antibiotic-resistant bacteria becoming a global health emergency, AlphaFold has helped researchers understand the proteins that bacteria use to pump antibiotics out of their cells — a crucial step toward designing drugs that can defeat those defenses.
Basic BiologyThousands of proteins in the human body have unknown functions. By examining AlphaFold's predicted shapes and comparing them to proteins whose functions are known, researchers can make educated guesses about what mystery proteins do — a process called structural genomics that is now happening at planetary scale.
Agricultural ScienceAlphaFold predictions for plant and fungal proteins are helping scientists understand crop diseases and develop more resilient agricultural varieties — with implications for food security in a warming world.
Synthetic Biology and Protein DesignAlphaFold's success inspired a new wave of tools that do the reverse — designing novel amino acid sequences that will fold into a desired shape. This field, pioneered by David Baker's laboratory, is now producing entirely new proteins that have never existed in nature, with potential applications from targeted therapeutics to biodegradable materials.

Prerequisites

What This Leads To

See Also

Transformer Architecture · Deep Learning · Reinforcement Learning from Human Feedback · AI for Scientific Discovery · Generative Models in Biology

Before this

Where this leads